PharmiWeb.com - Global Pharma News & Resources
01-Mar-2022

BeiGene to Present at the Cowen 42nd Annual Health Care Virtual Conference

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--$bgne #beigene--BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, today announced that the Company will participate in the Cowen 42nd Annual Health Care Conference on Monday, March 7, 2022 at 9:50 a.m. ET.

A live webcast can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com or http://hkexir.beigene.com. An archived replay will be available for 90 days following the event.

About BeiGene

BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. With a broad portfolio of more than 40 clinical candidates, we are expediting development of our diverse pipeline of novel therapeutics through our own capabilities and collaborations. We are committed to radically improving access to medicines for two billion more people by 2030. BeiGene has a growing global team of over 8,000 colleagues across five continents. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneGlobal.


Contacts

Investor Contact
Kevin Mannix
+1 857-302-5189
ir@beigene.com

Media Contact
Liza Heapes
+1 857-302-5663
media@beigene.com

Editor Details

  • Company:
    • Businesswire
Last Updated: 01-Mar-2022